These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19120397)

  • 61. Scanning electron microscopy of panitumumab-induced eyelash and hair alterations - Pili canaliculi.
    Sarzi Sartori D; Larangeira de Almeida A; Santana Pereira de Oliveira G; de Almeida HL
    An Bras Dermatol; 2022; 97(2):240-242. PubMed ID: 35042642
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Baboon syndrome induced by cetuximab.
    Sans V; Jouary T; Hubiche T; Smith D; Milpied B; Taieb A
    Arch Dermatol; 2008 Feb; 144(2):272-4. PubMed ID: 18283197
    [No Abstract]   [Full Text] [Related]  

  • 63. Trichomegaly Associated with Panitumumab.
    Goyal A; Blaes A
    N Engl J Med; 2020 Oct; 383(16):e94. PubMed ID: 33053288
    [No Abstract]   [Full Text] [Related]  

  • 64. Benign form of myasthenia gravis after nivolumab treatment.
    Sciacca G; Nicoletti A; Rampello L; Noto L; Parra HJ; Zappia M
    Muscle Nerve; 2016 Sep; 54(3):507-9. PubMed ID: 27287688
    [No Abstract]   [Full Text] [Related]  

  • 65. Severe Onycholysis and Eyelash Trichomegaly Following Use of New Selective Pan-FGFR Inhibitors.
    Bétrian S; Gomez-Roca C; Vigarios E; Delord JP; Sibaud V
    JAMA Dermatol; 2017 Jul; 153(7):723-725. PubMed ID: 28538953
    [No Abstract]   [Full Text] [Related]  

  • 66. [Acquired trichomegaly and hypertrichosis].
    Aerts L; Lauwers N; Smets RM
    J Fr Ophtalmol; 2014 Apr; 37(4):339-41. PubMed ID: 24576565
    [No Abstract]   [Full Text] [Related]  

  • 67. Familial trichomegaly.
    Harrison DA; Mullaney PB
    Arch Ophthalmol; 1997 Dec; 115(12):1602-3. PubMed ID: 9400804
    [No Abstract]   [Full Text] [Related]  

  • 68. Cyclosporine-induced trichomegaly.
    Weaver DT; Bartley GB
    Am J Ophthalmol; 1990 Feb; 109(2):239. PubMed ID: 2301544
    [No Abstract]   [Full Text] [Related]  

  • 69. Drug-induced hair colour changes.
    Bublin JG; Thompson DF
    J Clin Pharm Ther; 1992 Oct; 17(5):297-302. PubMed ID: 1464633
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Essential trichomegaly: case report.
    Rossetto JD; Nascimento H; Muccioli C; Belfort R
    Arq Bras Oftalmol; 2013; 76(1):50-1. PubMed ID: 23812530
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Eyelashes poliosis as first sign of metastatic melanoma.
    Burzi L; Parietti M; Agostini A; Marra E; Fierro MT; Ribero S; Quaglino P
    J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):e459-e460. PubMed ID: 33660293
    [No Abstract]   [Full Text] [Related]  

  • 72. Case of respiratory discomfort due to myositis after administration of nivolumab.
    Yoshioka M; Kambe N; Yamamoto Y; Suehiro K; Matsue H
    J Dermatol; 2015 Oct; 42(10):1008-9. PubMed ID: 26104017
    [No Abstract]   [Full Text] [Related]  

  • 73. Amiodarone and hair loss.
    Samuel LM; Davie M; Starkey IR
    Postgrad Med J; 1992 Sep; 68(803):771. PubMed ID: 1480548
    [No Abstract]   [Full Text] [Related]  

  • 74. Idiopathic, acquired, localised and transient trichomegaly.
    Samia-Aly E; Mellington F
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33727305
    [No Abstract]   [Full Text] [Related]  

  • 75. Essential Trichomegaly of the Eyelashes.
    Fernández-Crehuet P; Ruiz-Villaverde R
    Int J Trichology; 2016; 8(3):153-4. PubMed ID: 27625571
    [No Abstract]   [Full Text] [Related]  

  • 76. Drug-Induced Photosensitivity: Clinical Types of Phototoxicity and Photoallergy and Pathogenetic Mechanisms.
    Di Bartolomeo L; Irrera N; Campo GM; Borgia F; Motolese A; Vaccaro F; Squadrito F; Altavilla D; Condorelli AG; Motolese A; Vaccaro M
    Front Allergy; 2022; 3():876695. PubMed ID: 36238932
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differential Expression of Nitric Oxide Synthase Isoforms nNOS and iNOS in Patients with Non-Segmental Generalized Vitiligo.
    Vaccaro M; Irrera N; Cutroneo G; Rizzo G; Vaccaro F; Anastasi GP; Borgia F; Cannavò SP; Altavilla D; Squadrito F
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186858
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ocular Adverse Events Associated with Antibody-Drug Conjugates in Human Clinical Trials.
    Eaton JS; Miller PE; Mannis MJ; Murphy CJ
    J Ocul Pharmacol Ther; 2015 Dec; 31(10):589-604. PubMed ID: 26539624
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Spectrum of ocular toxicities from epidermal growth factor receptor inhibitors and their intermediate-term follow-up: a five-year review.
    Borkar DS; Lacouture ME; Basti S
    Support Care Cancer; 2013 Apr; 21(4):1167-74. PubMed ID: 23151647
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Trichomegaly of the eyelashes following treatment with cetuximab.
    Vaccaro M; Pollicino A; Barbuzza O; Guarneri B
    Clin Exp Dermatol; 2009 Apr; 34(3):402-3. PubMed ID: 19120397
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.